Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study

BACKGROUND: Several studies have suggested a survival benefit of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head. Data concerning NAT for PDAC located in pancreatic body or tail are lacking. METHODS: Post hoc analysis of an international multicenter retro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Lof, Sanne, Korrel, Maarten, van Hilst, Jony, Alseidi, Adnan, Balzano, Gianpaolo, Boggi, Ugo, Butturini, Giovanni, Casadei, Riccardo, Dokmak, Safi, Edwin, Bjørn, Falconi, Massimo, Keck, Tobias, Malleo, Giuseppe, de Pastena, Matteo, Tomazic, Ales, Wilmink, Hanneke, Zerbi, Alessandro, Besselink, Marc G., Abu Hilal, Mohammed
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Pancreatic Tumors
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210228/
https://ncbi.nlm.nih.gov/pubmed/31848815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08137-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados